bromocriptine การใช้

• Bromocriptine treatment should not be interrupted without consulting a qualified endocrinologist.
• The medication bromocriptine can reduce cravings and withdrawal symptoms within 24 hours.
• Bromocriptine acts in a completely different manner to the other treatments mentioned above.
• Bromocriptine is only prescribed in cases of overproduction of prolactin ( hyperprolactinemia ).
• Patients with prolactinoma treated with bromocriptine or cabergoline may also take oral contraceptives.
• These include doxorubicin, ergotamine preparations, lithium, methotrexate, cyclosporin and bromocriptine.
• Goepel and Pahnke and other authors recommend performing surgeries only with concomitant bromocriptine treatment.
• Widely known for nearly 20 years, bromocriptine is used in treating Parkinson's disease.
• Dietary protein restriction and the use of selegiline hydrochloride and bromocriptine may also temporarily improve motor fluctuations.
• By using bromocriptine, the company did not have to develop its own similar active ingredient for Ergoset.
• As with bromocriptine therapy, side-effects may be avoided or minimized if treatment is started slowly.
• In addition his work with prolactin helped to develop the drug bromocriptine, used for the treatment of infertility.
• It is isolated from ergot or fermentation broth and it serves as starting material for the production of bromocriptine.
• Bromocriptine increases the level of dopamine in the brain, which controls rhythmic biological cycles that recur every 24 hours.
• It was shown through various testing that administration of Bromocriptine can improve field of vision defects and lower prolactin levels.
• Bromocriptine has been shown by some studies to increase verbal fluency and word retrieval with therapy than with just therapy alone.
• A study by Goepel and Panhke provided indications that the inflammation should be controlled by bromocriptine even in absence of hyperprolactinemia.
• Treatment with a combination of glucocorticoids and prolactin lowering medications such as bromocriptine or cabergoline was used with good success in Germany.
• Hypoprolactinemia can result from hypopituitarism, excessive dopaminergic action in the tuberoinfundibular pathway and ingestion of D 2 receptor agonists such as bromocriptine.
• Prolactinomas may respond to dopamine agonist treatment medication that mimics the action of dopamine on the lactrotrope cells, usually bromocriptine or cabergoline.